News
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX – Research Report) and ...
Maxim analyst Naz Rahman downgraded Galmed (GLMD) to Hold from Buy. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter ...
Naz Rahman (Maxim Group) questioned the feasibility of the ... In Q&A, the tone remained proactive and detailed, addressing analyst concerns with specific examples and updates.
Fintel reports that on April 24, 2025, Maxim Group initiated coverage of Castellum (NYSEAM:CTM) with a Buy recommendation.
Fintel reports that on April 2, 2025, Maxim Group initiated coverage of Nuvectis Pharma (NasdaqCM:NVCT) with a Buy recommendation. Analyst Price Forecast Suggests 70.16% Upside As of April 2, 2025, ...
Fintel reports that on April 7, 2025, Maxim Group initiated coverage of Intchains ... Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment ...
Helius Medical Technologies has an analyst consensus of Hold. The company has a one-year high of $7.19 and a one-year low of $0.37. Currently, Helius Medical Technologies has an average volume of ...
The move sees her leaving her role as senior investment control analyst at Capital Group, which she had held since October 2022. “Welcoming Francesca Mace Wilson to the EMEA Equity trading desk at ...
In recent trading, shares of FinVolution Group (Symbol: FINV) have crossed above the average analyst 12-month target price of $10.23, changing hands for $10.46/share. When a stock reaches the ...
The standing of UnitedHealth Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations ...
The standing of Lucid Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations ...
Seaport Res Ptn analyst G. Chin now expects that the company will earn $9.67 per share for the quarter, up from their prior forecast of $9.24. The consensus estimate for Group 1 Automotive’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results